Sign up
Log in
12 Health Care Stocks Moving In Friday's Pre-Market Session
Share
Listen to the news

Gainers

  • Prenetics Global (NASDAQ:PRE) shares moved upwards by 17.8% to $9.45 during Friday's pre-market session. The market value of their outstanding shares is at $115.4 million. The company's, Q1 earnings came out yesterday.
  • Astria Therapeutics (NASDAQ:ATXS) shares moved upwards by 13.39% to $6.35. The market value of their outstanding shares is at $358.3 million.
  • Privia Health Gr (NASDAQ:PRVA) stock increased by 12.29% to $25.49. The market value of their outstanding shares is at $3.1 billion.
  • China Pharma Holding (AMEX:CPHI) stock moved upwards by 8.8% to $1.73. The market value of their outstanding shares is at $5.6 million.
  • Wellgistics Health (NASDAQ:WGRX) stock moved upwards by 7.09% to $1.51. The company's market cap stands at $108.5 million.
  • Tiziana Life Sciences (NASDAQ:TLSA) stock rose 7.04% to $1.52. The market value of their outstanding shares is at $177.6 million.

Losers

  • Rein Therapeutics (NASDAQ:RNTX) stock decreased by 18.8% to $1.6 during Friday's pre-market session. The market value of their outstanding shares is at $35.4 million.
  • Liminatus Pharma (NASDAQ:LIMN) shares decreased by 18.22% to $16.61. The company's market cap stands at $432.1 million.
  • bioAffinity Technologies (NASDAQ:BIAF) shares decreased by 17.22% to $0.25. The company's market cap stands at $6.8 million.
  • Healthcare Triangle (NASDAQ:HCTI) shares decreased by 15.67% to $0.03. The company's market cap stands at $10.3 million.
  • Catheter Precision (AMEX:VTAK) shares fell 13.96% to $0.37. The market value of their outstanding shares is at $4.0 million.
  • NuCana (NASDAQ:NCNA) stock decreased by 12.11% to $0.13. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.